Literature DB >> 31020327

RE: Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication.

Farzin Khosrow-Khavar, Siyana Kurteva, Antonios Douros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31020327      PMCID： PMC6792068          DOI： 10.1093/jnci/djz066

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN： 0027-8874            Impact factor:   13.506


× No keyword cloud information.
  5 in total

Review 1.  Immortal time bias in pharmaco-epidemiology.

Authors:  Samy Suissa
Journal:  Am J Epidemiol       Date:  2007-12-03       Impact factor: 4.897

2.  Metformin Use and Gastric Cancer Risk in Diabetic Patients After Helicobacter pylori Eradication.

Authors:  Ka Shing Cheung; Esther W Chan; Angel Y S Wong; Lijia Chen; Wai Kay Seto; Ian C K Wong; Wai K Leung
Journal:  J Natl Cancer Inst       Date:  2019-05-01       Impact factor: 13.506

Review 3.  Considerations for Pharmacoepidemiological Studies of Drug-Cancer Associations.

Authors:  Anton Pottegård; Søren Friis; Til Stürmer; Jesper Hallas; Shahram Bahmanyar
Journal:  Basic Clin Pharmacol Toxicol       Date:  2018-01-15       Impact factor: 4.080

4.  Evaluating medication effects outside of clinical trials: new-user designs.

Authors:  Wayne A Ray
Journal:  Am J Epidemiol       Date:  2003-11-01       Impact factor: 4.897

Review 5.  Metformin and the risk of cancer: time-related biases in observational studies.

Authors:  Samy Suissa; Laurent Azoulay
Journal:  Diabetes Care       Date:  2012-12       Impact factor: 19.112
  5 in total
  1 in total

Review 1.  Chemoprevention Against Gastric Cancer.

Authors:  Shailja C Shah; Richard M Peek
Journal:  Gastrointest Endosc Clin N Am       Date:  2021-07
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.